What Evvy does

Evvy is a New York-based precision women's health company that operates a direct-to-consumer platform anchored by the first and only CLIA/CAP/CLEP-certified at-home vaginal microbiome test. The flagship test uses metagenomic next-generation sequencing (mNGS) on a single self-collected swab to screen 700+ bacteria and fungi—versus 1–3 pathogens in standard OB-GYN testing—and is processed in Evvy's CLIA-certified lab with clinician-reviewed results, a personalized care plan, optional Rx treatment, and a free 1:1 health coaching session. The underlying AI/molecular signature discovery platform is built on what the company describes as the world's largest vaginal microbiome dataset (100,000+ samples) and was used to identify six distinct microbial subtypes of bacterial vaginosis that have been integrated into the test report and care pathway.

The company has expanded beyond the core diagnostic into a vertically integrated care stack. Product lines now include the UTI+ PCR urine test (12 uropathogens, 7 antibiotic resistance genes, 1-day results), a Women's Complete Probiotic with Evvy's proprietary Lactobacillus blend plus postbiotic, prescription vaginal suppositories (probiotic, boric acid, hyaluronic acid), hormone-related Rx products (Estradiol Vaginal Cream, anti-itch and soothing vulva creams), a Male Partner BV Treatment regimen, the multi-step Evvy Complete Treatment Program, and curated bundles. All Rx products are compounded at a 503a NABP-accredited pharmacy and prescribed by Evvy-affiliated providers via asynchronous telehealth.

Evvy monetizes through a hybrid one-time purchase plus subscription model. The flagship Vaginal Health Test is priced at $159 one-time or $129/test on a quarterly Evvy Membership (4 tests/year); the UTI+ Test is $248 one-time or $217.99 on quarterly subscription; probiotics, suppositories, and creams are priced $39–$69 with Subscribe & Save options delivering 10–20% discounts. Bundles (up to $348) drive AOV. Primary customer segments are women with recurrent vaginal symptoms, women on the fertility journey, women in perimenopause/menopause, and women with recurrent UTIs, supplemented by a smaller segment of male partners of women with recurrent BV. Distribution is entirely D2C through evvy.com with US-dominant reach and limited Canada availability; no third-party retail or enterprise channel is in use.

Name

Evvy

Legal name

Evvy

Website

https://evvy.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Evvy is a New York-based precision women's health company that sells the first CLIA-certified metagenomic at-home vaginal microbiome test, plus companion diagnostics (UTI+), telehealth-prescribed Rx products, and probiotics, serving women with recurrent vaginal symptoms, fertility, menopause, and recurrent UTI needs.

Ownership category

akta.pro rank

Product category

Women's Health Diagnostics

NAICS

Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Microbiome & Metagenomics Services (HLAGANAH)

akta.pro secondary industries

Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

• Vaginal microbiome testing
• At-home diagnostic tests
• Women's health platform
• Metagenomic sequencing services
• Prescription telehealth care

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

1. At-home Vaginal Health Test Sales: One-time and subscription sales of the flagship at-home Vaginal Microbiome Test at $159 one-time or $129/test on a quarterly membership (4 tests/year); includes Expanded PCR Panel add-on for +$89.
2. Membership/Subscription Revenue: Recurring Evvy Membership billing quarterly with auto-refills, providing discounted tests, continuous tracking of microbiome changes, free coaching, and subscription savings (~$30 per test). Skip or cancel anytime.
3. UTI+ Test Sales: One-time and subscription sales of the at-home UTI+ PCR urine test at $248 one-time or $217.99 on quarterly subscription; eligible customers can purchase targeted Rx treatment separately after results.
4. Probiotic & Supplement Sales: Direct-to-consumer sales of Women's Complete Probiotic ($55 one-time or $44/month on Subscribe & Save with 20% off), Vaginal Probiotic Suppositories ($59 one-time or $47.20/every 2 months with 20% off).
5. Prescription (Rx) Product Sales: Sales of compounded Rx products (Pure Boric Acid Suppositories $39, Hyaluronic Acid Suppositories $59, Estradiol Vaginal Cream $69, Anti-Itch Vulva Cream $59, Soothing Vulva Cream $59, Evvy Complete Treatment Program) prescribed by Evvy-affiliated providers, priced separately from tests and dispensed via 503a NABP-accredited pharmacy.
6. Bundle Sales: Bundled product collections with 10-15% discounts: Vaginal Health & UTI+ Test Bundle ($348), Women's Probiotic Bundle ($97), Vaginal Health Test & Probiotic Bundle ($192.60), Vaginal Health Test 2-Pack ($258).

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels7 records

Core offering

Evvy sells direct-to-consumer at-home vaginal microbiome tests using metagenomic next-generation sequencing (mNGS) that screen 700+ bacteria and fungi from a single swab, plus companion diagnostics (UTI+ PCR Test), oral and vaginal probiotic supplements, and compounded prescription products (boric acid, hyaluronic acid, estradiol creams, suppositories). Results are clinician-reviewed and paired with personalized care plans, 1:1 coaching, eligibility for Rx treatment, and ongoing tracking through a quarterly membership subscription model.

Product overview

Evvy operates as a single integrated precision women's health platform centered on the at-home Vaginal Health Test, which is augmented by optional add-ons (Expanded PCR Panel), companion diagnostics (UTI+ Test), daily supplements (Women's Complete Probiotic), targeted Rx products (Vaginal Probiotic Suppositories, Pure Boric Acid Suppositories, Hyaluronic Acid Suppositories, Estradiol Vaginal Cream, Anti-Itch Vulva Cream, Soothing Vulva Cream, Male Partner BV Treatment), a personalized Complete Treatment Program, and curated bundles (Vaginal Health & UTI+ Test Bundle, Women's Probiotic Bundle, Vaginal Health Test & Probiotic Bundle, Vaginal Health Test 2-Pack). The core test feeds a care platform that combines metagenomic sequencing, clinician review, and an Evvy Membership subscription model to deliver personalized insights, fertility and menopause support, BV subtyping, and prescription treatment pathways across vaginal symptoms, fertility, UTIs, and peri/menopause.

Differentiator

Problem solved

Functional benefit

Brands

• Evvy Vaginal Health Test: Evvy's flagship at-home CLIA-certified, mNGS vaginal microbiome test that screens for 700+ bacteria and fungi.
• Women's Complete Probiotic
• Vaginal Probiotic Suppositories
• UTI+ Test
• Evvy Complete Treatment Program
• Equal Research Day

Products and services

• Evvy Vaginal Health Test CLIA/CAP/CLEP-certified at-home vaginal microbiome test using metagenomic sequencing (mNGS) to screen for 700+ bacteria and fungi from a single swab, returning clinician-reviewed results in 7-10 business days with a personalized care plan, 1:1 coaching, and optional Rx treatment eligibility. Priced at $159 one-time or $129/test on a quarterly Evvy Membership.
• Expanded PCR Panel (STI + PCR add-on) Optional $89 add-on to the Vaginal Health Test that uses PCR to detect 4 STIs (chlamydia, gonorrhea, trich, Mycoplasma genitalium), 11 common microbes with microbial load, and 10 antibiotic resistance classes, with preliminary results in 1-3 business days.
• Evvy UTI+ Test At-home PCR urine test that identifies 12 uropathogens and 7 antibiotic resistance genes with results in 1 business day, plus eligibility for same-day Rx pickup from an Evvy-affiliated provider. Priced at $248 one-time or $217.99 on a quarterly subscription.
• Women's Complete Probiotic Daily oral probiotic capsule formulated for 3-in-1 gut, urinary, and vaginal microbiome support, built on Evvy's proprietary blend (Lactobacillus reuteri RC-14, Lactobacillus rhamnosus GR-1, Lactobacillus crispatus LBV88, Lactobacillus acidophilus ProbioTec LA-5, Lactobacillus plantarum UALp-05) plus postbiotic tributyrin and vitamins D3 & E. Priced at $55 one-time or $44/month on subscription; 4.75B CFU at end of shelf life.
• Vaginal Probiotic Suppositories Prescription vaginal suppositories delivering Evvy's multi-strain Lactobacillus blend (L. crispatus, GR-1/RC-14) plus lactoferrin and vitamin E directly to the vagina to restore pH and reduce odor/discharge. Compounded at a 503a NABP-accredited pharmacy; 20 suppositories for $59 one-time or $47.20 every 2 months.
• Pure Boric Acid Suppositories Prescription-grade 600 mg boric acid vaginal suppositories compounded at a 503a NABP-accredited pharmacy to manage vaginal odor, pH imbalance, and recurrent symptoms. 12 suppositories for $39 one-time or $35.10 every 2 months on subscription.
• Hyaluronic Acid Suppositories Prescription-grade hormone-free vaginal suppositories combining 5 mg hyaluronic acid with a moisturizing pH-balanced fatty-acid base for relief of dryness, itching, and painful sex in menopause, postpartum, or medication-induced dryness. 12 suppositories for $59 one-time or $53.10 every 2 months on subscription.
• Estradiol Vaginal Cream Paraben- and sulfate-free localized low-dose estradiol vaginal cream for menopausal dryness and related symptoms, part of Evvy's menopause-focused platform combining microbiome testing with hormone therapy. Priced at $69.
• Anti-Itch Vulva Cream Rx topical vulva cream for quickly calming itching and irritation, available through Evvy's prescription symptom-relief line. Priced at $59.
• Soothing Vulva Cream

Quantifiable outcome

• 100,000+ users supported
• +8 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature7 records

Partnerships

Eight partnerships are on record, tiered major (joint awareness campaign), moderate (campaign participant), major (strategic diagnostic partner) and moderate (payment integration).

• Teal Healthmajor (joint awareness campaign)GTM or Marketing Partner · 1 January 2026Joined Teal Health's joint awareness campaign with 30+ women-focused health companies to eliminate cervical cancer during Cervical Cancer Awareness Month (January 2026). Promotes FDA-authorized self-collection testing as alternative to traditional speculum exams.
• Midi Healthmoderate (campaign participant)GTM or Marketing Partner · 1 January 2026Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy and other women-focused health companies (January 2026).
• Maven Clinicmoderate (campaign participant)GTM or Marketing Partner · 1 January 2026Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).
• Wispmoderate (campaign participant)GTM or Marketing Partner · 1 January 2026Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).
• Kindbodymoderate (campaign participant)GTM or Marketing Partner · 1 January 2026Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).
• The Flex Companymoderate (campaign participant)GTM or Marketing Partner · 1 January 2026Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).
• Labcorpmajor (strategic diagnostic partner)Strategic or Co-development PartnerLabcorp logo is displayed prominently on Evvy's homepage alongside its venture fund. Labcorp Venture Fund participated in Evvy's $14M Series A, indicating a strategic diagnostic industry partnership supporting Evvy's lab services and testing infrastructure.
• TrueMedmoderate (payment integration)Technology or IntegrationEvvy has partnered with TrueMed to streamline HSA/FSA payments for US customers. Users can choose 'TrueMed' as a payment method during checkout to complete HSA/FSA-eligible purchases.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Daye: UK-based femtech company that also offers at-home vaginal microbiome screening and CBD-based tampons/suppositories; directly comparable to Evvy as a DTC vaginal-health diagnostic and care brand targeting the same end consumer.
• Midi Health: Virtual care clinic focused on perimenopause and menopause; directly comparable to Evvy's menopause workstream (Estradiol Vaginal Cream, Hyaluronic Acid Suppositories) and a co-marketing partner in Teal Health's cervical cancer campaign.
• Maven Clinic: Virtual care platform for women's and family health (fertility, maternity, menopause); comparable to Evvy in target customer and adjacency to Evvy's fertility and menopause use cases, and a co-marketing partner in Teal Health's campaign.
• Wisp: DTC telehealth and prescription company for vaginal infections, UTIs, and herpes; competes with Evvy's UTI+ Test, Boric Acid Suppositories, and Hyaluronic Acid Suppositories in the same OTC/Rx women's health category.

Broad incumbents

• Thorne: Premium DTC supplements and diagnostics brand; comparable to Evvy's Women's Complete Probiotic and broader at-home testing category, with overlapping premium positioning and HSA/FSA payment rails.
• Oura: Consumer wearable health platform (smart ring) with women's health features and a large individual user base; comparable to Evvy as a premium consumer health-data brand monetizing longitudinal personal health data.
• Nurx: Established telehealth provider for women's health (birth control, STI testing, HPV, UTI treatment); comparable to Evvy's telehealth + at-home test + Rx model and an established incumbent in DTC women's diagnostics.

Regional players

• OVRY: Canadian-based DTC women's health brand selling ovulation and vaginal-health products; comparable to Evvy as a femtech supplement and vaginal health brand with similar target customer, though regional to Canada.

Emerging players

• Kindbody: Fertility-focused women's health company with at-home and clinic-based services; comparable to Evvy's fertility-journey customer segment and a co-marketing partner in Teal Health's cervical cancer campaign.
• Teal Health: Women's health startup focused on at-home cervical cancer screening; comparable as a femtech DTC diagnostic adjacent to Evvy's STI/PCR panel and a current co-marketing partner.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/evvy
• TikToktiktok.com/@evvybio
• Xx.com/evvybio
• Facebookfacebook.com/evvybio
• LinkedInlinkedin.com/company/evvybio

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds3 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evvy